Although our patients did not have prior symptoms suggestive of MG, it is possible that they had subclinical immunodeficiency and anti-LRP4 antibody may have caused additional symptoms after the onset of ALS in the context of the progression of axonal loss. Here, LRP4 is linked to immune system disorder.